scispace - formally typeset
K

Kelly-Anne Phillips

Researcher at Peter MacCallum Cancer Centre

Publications -  207
Citations -  12590

Kelly-Anne Phillips is an academic researcher from Peter MacCallum Cancer Centre. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 47, co-authored 188 publications receiving 9898 citations. Previous affiliations of Kelly-Anne Phillips include Mount Sinai Hospital & University of Melbourne.

Papers
More filters
Journal ArticleDOI

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers

Karoline Kuchenbaecker, +67 more
- 20 Jun 2017 - 
TL;DR: To estimate age-specific risks of breast, ovarian, and contralateral breast cancer for mutation carriers and to evaluate risk modification by family cancer history and mutation location, a large cohort study recruited in 1997-2011 provides estimates of cancer risk based on BRCA1 and BRCa2 mutation carrier status.
Journal ArticleDOI

Association analysis identifies 65 new breast cancer risk loci

Kyriaki Michailidou, +396 more
- 02 Nov 2017 - 
TL;DR: A genome-wide association study of breast cancer in 122,977 cases and 105,974 controls of European ancestry and 14,068 cases and 13,104 controls of East Asian ancestry finds that heritability of Breast cancer due to all single-nucleotide polymorphisms in regulatory features was 2–5-fold enriched relative to the genome- wide average.
Journal ArticleDOI

Cognitive function in breast cancer patients receiving adjuvant chemotherapy.

TL;DR: Cognitive differences were observed in breast cancer patients receiving adjuvant chemotherapy compared with healthy controls, and these differences did not seem to be caused by significant differences in mood disturbance between the two groups.
Journal ArticleDOI

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.

Timothy R. Rebbeck, +261 more
- 07 Apr 2015 - 
TL;DR: In this paper, the relationship between specific mutations in BRCA1 and cancer risk has been investigated and limited information about the relationship has been available about specific mutations for specific mutations.